A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia
Clinical trial NCT06302491 · RECRUITING
Trial details
- NCT number
- NCT06302491
- Sponsor
- Kind Pharmaceuticals LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-27
- Primary completion
- 2026-12-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.